A leading pharma company was planning a Phase III trial for a SARS-CoV-2 prophylactic therapy. They needed to evaluate post-exposure prophylaxis and preemptive treatment in 1,000+ patients at 82 sites. The challenges: patients were over the age of 60, lived in long-term care facilities, and were unable to make off-site clinic visits due to possible virus exposure. Because televisits were not a feasible alternative, the trial required collection of data from the patients in these facilities, including supporting information such as audiovisual materials and images.
Discover the solution to this challenge and the results in this case study.